What Researchers Did
Researchers conducted a systematic review, meta-analysis, and a retrospective chart review to evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) for central retinal artery occlusion (CRAO).
What They Found
The meta-analysis, including 207 patients who received HBOT and 89 controls, found that HBOT did not significantly improve the final visual outcome in CRAO patients (p = 0.83). A retrospective analysis of 48 patients (15 HBOT, 33 controls) at a tertiary care center similarly showed no visual benefit from HBOT.
What This Means for Canadian Patients
Canadian patients with central retinal artery occlusion (CRAO) should be aware that hyperbaric oxygen therapy (HBOT) may not improve their visual outcomes. This suggests that current treatment approaches for CRAO may need to focus on other interventions or supportive care.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in the USA and did not include Canadian participants or data.
Study Limitations
The meta-analysis was limited by the small number of included studies (only three articles) and the retrospective nature of the institutional data.